Cargando…
Heterologous prime-boost vaccination against COVID-19: is it safe and reliable?
Throughout the globe, many nations are struggling to cope with the consecutive waves of the COVID-19. Several vaccines have been employed to overcome this ongoing pandemic and are available as single and double-dose inoculations; however, homologous vaccine efficacy is being reconsidered due to the...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726007/ https://www.ncbi.nlm.nih.gov/pubmed/34898381 http://dx.doi.org/10.1080/21645515.2021.2007015 |
_version_ | 1784626234556153856 |
---|---|
author | Choudhary, Om Prakash Priyanka, Ahmed, Jivan Q. Mohammed, Teroj A. Singh, Indraj Rodriguez-Morales, Alfonso J. |
author_facet | Choudhary, Om Prakash Priyanka, Ahmed, Jivan Q. Mohammed, Teroj A. Singh, Indraj Rodriguez-Morales, Alfonso J. |
author_sort | Choudhary, Om Prakash |
collection | PubMed |
description | Throughout the globe, many nations are struggling to cope with the consecutive waves of the COVID-19. Several vaccines have been employed to overcome this ongoing pandemic and are available as single and double-dose inoculations; however, homologous vaccine efficacy is being reconsidered due to the rapidly emerging SARS-CoV-2 variants. Many studies have been conducted on the heterologous prime-boost vaccine regimens and have shown good efficacy results against COVID-19. This article aims to highlight the safety and reliability of heterologous prime-boost vaccination against COVID-19. We have also made some recommendations towards using these combinations of vaccines for the global mitigation of the subsequent waves of COVID-19. |
format | Online Article Text |
id | pubmed-8726007 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Taylor & Francis |
record_format | MEDLINE/PubMed |
spelling | pubmed-87260072022-01-05 Heterologous prime-boost vaccination against COVID-19: is it safe and reliable? Choudhary, Om Prakash Priyanka, Ahmed, Jivan Q. Mohammed, Teroj A. Singh, Indraj Rodriguez-Morales, Alfonso J. Hum Vaccin Immunother Commentary Throughout the globe, many nations are struggling to cope with the consecutive waves of the COVID-19. Several vaccines have been employed to overcome this ongoing pandemic and are available as single and double-dose inoculations; however, homologous vaccine efficacy is being reconsidered due to the rapidly emerging SARS-CoV-2 variants. Many studies have been conducted on the heterologous prime-boost vaccine regimens and have shown good efficacy results against COVID-19. This article aims to highlight the safety and reliability of heterologous prime-boost vaccination against COVID-19. We have also made some recommendations towards using these combinations of vaccines for the global mitigation of the subsequent waves of COVID-19. Taylor & Francis 2021-12-13 /pmc/articles/PMC8726007/ /pubmed/34898381 http://dx.doi.org/10.1080/21645515.2021.2007015 Text en © 2021 Taylor & Francis Group, LLC |
spellingShingle | Commentary Choudhary, Om Prakash Priyanka, Ahmed, Jivan Q. Mohammed, Teroj A. Singh, Indraj Rodriguez-Morales, Alfonso J. Heterologous prime-boost vaccination against COVID-19: is it safe and reliable? |
title | Heterologous prime-boost vaccination against COVID-19: is it safe and reliable? |
title_full | Heterologous prime-boost vaccination against COVID-19: is it safe and reliable? |
title_fullStr | Heterologous prime-boost vaccination against COVID-19: is it safe and reliable? |
title_full_unstemmed | Heterologous prime-boost vaccination against COVID-19: is it safe and reliable? |
title_short | Heterologous prime-boost vaccination against COVID-19: is it safe and reliable? |
title_sort | heterologous prime-boost vaccination against covid-19: is it safe and reliable? |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8726007/ https://www.ncbi.nlm.nih.gov/pubmed/34898381 http://dx.doi.org/10.1080/21645515.2021.2007015 |
work_keys_str_mv | AT choudharyomprakash heterologousprimeboostvaccinationagainstcovid19isitsafeandreliable AT priyanka heterologousprimeboostvaccinationagainstcovid19isitsafeandreliable AT ahmedjivanq heterologousprimeboostvaccinationagainstcovid19isitsafeandreliable AT mohammedteroja heterologousprimeboostvaccinationagainstcovid19isitsafeandreliable AT singhindraj heterologousprimeboostvaccinationagainstcovid19isitsafeandreliable AT rodriguezmoralesalfonsoj heterologousprimeboostvaccinationagainstcovid19isitsafeandreliable |